RecruitingRecruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
NCT07754461 · Boehringer Ingelheim
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
A Phase III, Randomised, Double-blind, Parallel-group, 56-week Study, Evaluating the Efficacy and Safety of Survodutide (BI 456906), Compared With Placebo, in Participants With Type 2 Diabetes, as an Adjunct to Diet and Physical Activity Alone or in Combination With Either Oral Antidiabetic Medications or Insulin
About this study
This study aims to find out whether a study medicine called survodutide helps people control their blood sugar. Adults who live with type 2 diabetes and with a body mass index (BMI) of 23 kg/m2 or higher can join.
The study has 3 parts. In each part the study compares survodutide with placebo. Survodutide is being developed to treat several health problems including type 2 diabetes. Placebo looks like survodutide but does not contain any medicine.
Depending on a person's diabetes treatment, a person will be assigned either to
* Part A: healthy eating and physical activity
* Part B: diabetes tablets (no injection of insulin)
* Part C: injection of insulin (with or without diabetes tablets)
Participants are randomly put into 1 of 3 groups, which means the group is chosen by chance. Two groups of participants get survodutide at different dose levels, and the third group gets placebo as injection under the skin once a week. You have a 2 in 3 chance of getting survodutide. During the study, participants continue their regular diabetes treatment.
Participants are in the study for about 1 year and 2 months. During this time, they attend up to 12 visits at the site and receive at least 9 phone calls. Study doctors regularly test participants' blood sugar by checking their HbA1c values and other laboratory test results. The study doctor also regularly checks participants' health and takes note of any changes. For each study part, the results will be compared between the survodutide and the placebo group to see whether the treatment works.
Eligibility criteria
Inclusion criteria:
1. Male or female, age ≥18 years at the time of signing informed consent, and at least the legal age of consent in countries where it is \>18 years
2. Diagnosed with type 2 diabetes mellitus (T2D) (e.g. American diabetes association (ADA)/European association for the study of diabetes (EASD) guidelines) and must meet requirements for one of background therapy parts A, B or C:
1. Part A: Naïve to insulin therapy and have not used oral or injectable anti-hyperglycaemic (diabetes) medication for at least 90 days prior to screening (Visit 1) and glycosylated haemoglobin A1c (HbA1c) ≥7.0 (≥53 mmol/mol) and \<9.5% (\<80 mmol/mol) as measured by the central laboratory at screening (Visit 1);
2. Part B: Treated with stable dose of oral antidiabetic medication (OAD) for 90 days prior to screening (Visit 1) as monotherapy or combination of: Maximum tolerated dose of metformin and/or Maximum tolerated dose of sulfonylurea and/or Maximum tolerated dose of sodium-glucose cotransporter 2 inhibitor (SGLT2i) and HbA1c ≥7.0% (≥53 mmol/mol) and \<10.5% (\<91 mmol/mol) as measured by the central laboratory at screening (Visit 1);
3. Part C: Stable use of basal insulin at a dose of ≥20 international units (IU)/day with or without stable dose of metformin and/or SGLT2i for 90 days prior to screening (Visit 1) and HbA1c ≥7.0% (≥53 mmol/mol) and \<10.5% (\<91 mmol/mol) as measured by the central laboratory at screening (Visit 1)
3. Body mass index (BMI) ≥23 kg/m2 at screening (Visit 1)
4. Signed and dated written informed consent in accordance with international council for harmonisation - good clinical practice (ICH-GCP) and local legislation prior to admission to the trial
5. Woman (or women) of childbearing potential (WOCBP) must be ready and able to use highly effective methods of birth control per international council for harmonisation of technical requirements for pharmaceuticals for human use M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly.
6. In the investigator's opinion, participants are well-motivated, capable, and willing to: Learn how to self-inject the investigational medicinal product (IMP), as required for this protocol (persons with physical limitations who are not able to perform the injections must have the assistance of an individual trained to inject the IMP); Inject the IMP or accept injection from a designated person; Follow study procedures for the duration of the study, including, but not limited to: follow lifestyle advice (for example, dietary restrictions and exercise plan), maintain a diary, complete required questionnaires, and handle the IMP as described in the instructions for use (IFU)
Exclusion criteria:
1. Type 1 diabetes mellitus (T1D) or latent autoimmune diabetes in adults (LADA)
2. Treatment within 90 days before screening (Visit 1) up to and including randomisation (Visit 2) with any: glucagon-like peptide-1 receptor (GLP-1R) agonists including GLP-1R agonist/glucose-dependent insulinotropic polypeptide (GIP) combinations, amylin or incretin combinations; Glucose-lowering drugs other than stated in the inclusion criteria for each part (i.e. metformin, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i), basal insulin, depending on the background therapy part); Glucose-lowering investigational drug; Any anti-obesity medication including bupropion/naltrexone, orlistat, phentermine, and phentermine/topiramate
3. History of ketoacidosis or hyperosmolar state or coma within the last 6 months before screening (Visit 1) up to and including randomisation (Visit 2)
4. Hypoglycaemia unawareness or a history of severe hypoglycaemia within the last 3 months before screening (Visit 1) up to and including randomisation (Visit 2)
5. Diabetic retinopathy or maculopathy currently under treatment, or that is reasonably anticipated to require such treatment over the duration of the study
6. Body weight change (self-reported) \>5% within 90 days before screening (Visit 1)
7. Previous or planned (during the trial period) treatment for obesity with surgery or a weight loss device, including any prior bariatric surgery. The following are allowed: (1) liposuction and/or abdominoplasty, if performed \>1 year before screening (Visit 1), (2) lap banding, if the band has been removed \>1 year before screening (Visit 1), (3) intragastric balloon, if the balloon has been removed \>1 year before screening (Visit 1), (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed \>1 year before screening (Visit 1).
8. Answered "yes" to any of the suicide-related behaviours (Actual attempt, Interrupted attempt, Aborted attempt, Preparatory act or behaviour) or to the non-suicidal self-injurious behaviour question on the "Suicidal Behaviour" section of the Columbia-Suicide Severity Rating Scale (C-SSRS) related to the past 2 years before screening (Visit 1) up to and including randomisation (Visit 2)
9. Further exclusion criteria apply.
Study design
Enrollment target: 600 participants
Allocation: randomized
Masking: quadruple
Age groups: adult, older_adult
Timeline
Starts: 2026-08-24
Estimated completion: 2028-05-01
Last updated: 2026-11-13
Interventions
Drug: PlaceboDrug: Survodutide
Primary outcomes
- • Absolute change in glycosylated haemoglobin A1c (HbA1c) (%) from baseline to Week 41 (At baseline and Week 41.)
Sponsor
Boehringer Ingelheim · industry
Contacts & investigators
ContactBoehringer Ingelheim · contact · clintriage.rdg@boehringer-ingelheim.com · 1-800-243-0127
All locations (121)
Cahaba Research, Inc. - Trussville LocationRecruiting
Birmingham, Alabama, United States
Mission Research Institute - GilbertRecruiting
Gilbert, Arizona, United States
Helios Clinical Research - Paradise ValleyRecruiting
Paradise Valley, Arizona, United States
Arizona Liver Health - Peoria 85381Recruiting
Peoria, Arizona, United States
Helios Clinical Research - PhoenixRecruiting
Phoenix, Arizona, United States
Woodland International Research Group, Inc.Recruiting
Little Rock, Arkansas, United States
San Fernando Valley HealthRecruiting
Canoga Park, California, United States
John Muir Physician Network Clinical Research CenterRecruiting
Concord, California, United States
Neighborhood Healthcare - EscondidoRecruiting
Escondido, California, United States
Clinical Trials Research - LincolnRecruiting
Lincoln, California, United States
ARK Clinical ResearchRecruiting
Long Beach, California, United States
Infinity Clinical ResearchRecruiting
Norco, California, United States
Valley Clinical Trials, Inc.Recruiting
Northridge, California, United States
Fomat Medical ResearchRecruiting
Oxnard, California, United States
Paradigm Clinical Research - San DiegoNot Yet Recruiting
San Diego, California, United States
Encompass Clinical Research, Spring ValleyRecruiting
Spring Valley, California, United States
University Clinical Investigators, Inc.Recruiting
Tustin, California, United States
Diablo Clinical ResearchRecruiting
Walnut Creek, California, United States
Focus Clinical ResearchRecruiting
West Hills, California, United States
Clinical Research of West Florida, Inc.Recruiting
Clearwater, Florida, United States
Northeast Research InstituteRecruiting
Fleming Island, Florida, United States
Covenant Metabolic Specialists, LLC - Fort MyersRecruiting
Fort Myers, Florida, United States
Encore Medical ResearchRecruiting
Hollywood, Florida, United States
Northeast Research InstituteRecruiting
Jacksonville, Florida, United States
Accel Research Sites - LakelandRecruiting
Lakeland, Florida, United States
Clinical Research of Central Florida - LakelandRecruiting
Lakeland, Florida, United States
Tampa Bay Medical Research - LargoRecruiting
Largo, Florida, United States
New Horizon Research Center-Miami-69732Recruiting
Miami, Florida, United States
South Broward ResearchRecruiting
Miramar, Florida, United States
Covenant Metabolic Specialists, LLC - BrandonRecruiting
Riverview, Florida, United States
Covenant Metabolic Specialists, LLC - SarasotaRecruiting
University Park, Florida, United States
Metabolic Research Institute, Inc.Recruiting
West Palm Beach, Florida, United States
Encore Medical Research - WestonRecruiting
Weston, Florida, United States
Conquest ResearchRecruiting
Winter Park, Florida, United States
Centricity Research, Endocrine ConsultantsRecruiting
Columbus, Georgia, United States
Javara-Fayetteville-67354Recruiting
Fayetteville, Georgia, United States
Balanced Life Health Care SolutionsNot Yet Recruiting
Lawrenceville, Georgia, United States
Rophe Adult and Pediatric MedicineNot Yet Recruiting
Union City, Georgia, United States
Pacific Diabetes & Endocrine CenterNot Yet Recruiting
Honolulu, Hawaii, United States
Elite Clinical Trials - BlackfootRecruiting
Blackfoot, Idaho, United States
Family First Clinical ResearchRecruiting
Idaho Falls, Idaho, United States
Solaris Clinical ResearchRecruiting
Meridian, Idaho, United States
Evanston Premier Healthcare Research LLCRecruiting
Skokie, Illinois, United States
Cotton O'Neil MulvaneRecruiting
Topeka, Kansas, United States
AMR LexingtonRecruiting
Lexington, Kentucky, United States
Endocrine and Metabolic ConsultantsNot Yet Recruiting
Rockville, Maryland, United States
Northern Pines Health Center - BuckleyRecruiting
Buckley, Michigan, United States
Revival Research Institute, LLC - DearbornRecruiting
Dearborn, Michigan, United States
Arcturus Healthcare - Troy Internal Medicine Research DivisionRecruiting
Troy, Michigan, United States
International Diabetes CenterNot Yet Recruiting
Minneapolis, Minnesota, United States
Olive Branch Family Medical CenterRecruiting
Olive Branch, Mississippi, United States
SKY Clinical Research Network Group - RidgelandRecruiting
Ridgeland, Mississippi, United States
StudyMetrix Research, LLCRecruiting
City of Saint Peters, Missouri, United States
Logan Health Research - KalispellNot Yet Recruiting
Kalispell, Montana, United States
Boeson Research - MissoulaRecruiting
Missoula, Montana, United States
Palm Research CenterRecruiting
Las Vegas, Nevada, United States
Albuquerque Clinical TrialsRecruiting
Albuquerque, New Mexico, United States
Ellipsis Research Group - BrooklynRecruiting
Brooklyn, New York, United States
Javara Inc. - Cape Fear Valley Medical CenterRecruiting
Fayetteville, North Carolina, United States
PharmQuest Life SciencesRecruiting
Greensboro, North Carolina, United States
Centricity Research - Morehead CityRecruiting
Morehead City, North Carolina, United States
Diabetes & Endocrinology Associates of Stark CountyRecruiting
Canton, Ohio, United States
Advanced Medical Research - MaumeeRecruiting
Maumee, Ohio, United States
New Venture Medical ResearchRecruiting
Wadsworth, Ohio, United States
Tekton Research Oklahoma CityRecruiting
Oklahoma City, Oklahoma, United States
Heritage Valley Medical GroupRecruiting
Beaver, Pennsylvania, United States
Preferred Primary Care Physicians-Pittsburgh-63932Recruiting
Pittsburgh, Pennsylvania, United States
Preferred Primary Care PhysiciansRecruiting
Pittsburgh, Pennsylvania, United States
Preferred Primary Care Physicians - Matthew DriveRecruiting
Uniontown, Pennsylvania, United States
PanAmerican Clinical Research - BlufftonNot Yet Recruiting
Bluffton, South Carolina, United States
Spartanburg Medical ResearchCompleted
Spartanburg, South Carolina, United States
University Diabetes & Endocrine ConsultantsRecruiting
Chattanooga, Tennessee, United States
LifeDoc Research, PLLCNot Yet Recruiting
Memphis, Tennessee, United States
Texas Diabetes and Endocrinology - Central AustinRecruiting
Austin, Texas, United States
South Texas Research Institute - BrownsvilleRecruiting
Brownsville, Texas, United States
Privia Medical Group Gulf Coast, PLLCRecruiting
Conroe, Texas, United States
University of Texas Southwestern Medical CenterNot Yet Recruiting
Dallas, Texas, United States
Pinnacle Clinical Research - GeorgetownRecruiting
Georgetown, Texas, United States
Juno Research, LLCRecruiting
Houston, Texas, United States
Biopharma Informatic, Inc. Research CenterRecruiting
Houston, Texas, United States
Research Physicians NetworkRecruiting
Houston, Texas, United States
Southern Endocrinology AssociatesNot Yet Recruiting
Mesquite, Texas, United States
Pinnacle Clinical Research - San AntonioRecruiting
San Antonio, Texas, United States
Pinnacle Clinical Research, LLCRecruiting
San Antonio, Texas, United States
Consano Clinical ResearchRecruiting
Shavano Park, Texas, United States
Texas Valley Clinical ResearchRecruiting
Weslaco, Texas, United States
Olympus Family MedicineRecruiting
Salt Lake City, Utah, United States
Tidewater Physicians Multispecialty GroupNot Yet Recruiting
Newport News, Virginia, United States
ERA Health Research - RedmondRecruiting
Redmond, Washington, United States
Clinical Investigation Specialists, Inc.-Kenosha-69111Recruiting
Kenosha, Wisconsin, United States
Royal Prince Alfred HospitalRecruiting
Camperdown, New South Wales, Australia
Logan HospitalNot Yet Recruiting
Meadowbrook, Queensland, Australia
Southern Adelaide Diabetes & Endocrine servicesRecruiting
Oaklands Park, South Australia, Australia
Baker Heart and Diabetes InstituteRecruiting
Melbourne, Victoria, Australia
Fraser Clinical TrialsRecruiting
New Westminster, British Columbia, Canada
Centricity Research (Brampton)Recruiting
Brampton, Ontario, Canada
Centricity Research (Vaughan)Recruiting
Concord, Ontario, Canada
Centricity Research (Nepean)Recruiting
Nepean, Ontario, Canada
Centricity Research (Bayview)Recruiting
Toronto, Ontario, Canada
Diabetes Heart Research CentreRecruiting
Toronto, Ontario, Canada
Albion Finch Medical CentreRecruiting
Toronto, Ontario, Canada
Applied Medical Informatics Research Inc.Recruiting
Montreal, Quebec, Canada
Endocrinologie Oasis IncRecruiting
Montreal, Quebec, Canada
Recherche Clinique Sigma Inc.Recruiting
Québec, Canada
Gujarat Endocrine CentreNot Yet Recruiting
Ahmedabad, India
Sardar Vallabhbhai Patel Institute of Medical Sciences and ResearchNot Yet Recruiting
Ahmedabad, India
AIIMS BhubaneshwarNot Yet Recruiting
Bhubaneswar, India
S.C.B. Medical College & HospitalNot Yet Recruiting
Cuttack, India
Osmania Medical College & HospitalNot Yet Recruiting
Hyderabad, Afzalgunj, India
Shree Mahalaxmi Diatone InstituteNot Yet Recruiting
Kolhāpur, India
Sanjay Gandhi Post Graduate Institute of Medical SciencesNot Yet Recruiting
Lucknow, India
Diabetes Care and Research CentreNot Yet Recruiting
Nagpur, India
Supe Heart & Diabetes Hospital & Research CentreNot Yet Recruiting
Nashik, India
AIIMS, New DelhiNot Yet Recruiting
New Delhi, India
Deenanath Mangeshkar Hospital and Research CentreNot Yet Recruiting
Pune, India
Jothydev's Diabetes Research CentreNot Yet Recruiting
Trivandrum, India
Vishakha Institute of Medical SciencesNot Yet Recruiting
Visakhapatnam, India
Momentum Clinical Research DunedinRecruiting
Central Dunedin, Dunedin, New Zealand
Waitemata Clinical ResearchRecruiting
Auckland, New Zealand
Clinical Trials New Zealand LtdRecruiting
Hamilton, New Zealand
Isis Clinical Research CenterRecruiting
Guaynabo, Puerto Rico